Lifestyle Medicine
BehavioralThe intervention is a series of lifestyle medicine consultations.
NCT Number: NCT07673172
Obesity is one of the most common health conditions among autistic young people and its prevalence rises at faster rates for autistic-relative to non-autistic-individuals. This places them at heightened risk for cardiovascular disease (CVD) and mortality before they enter adulthood. Studies have identified three key contributing factors to CVD outcomes in autistic individuals: unhealthy lifestyle behaviors, Adverse Childhood Experiences (ACEs), and chronic stress.
This study will explore the effectiveness of two CVD-focused primary care interventions for autistic individuals (ages 9-26): (1) lifestyle medicine consultations tailored towards supporting health-promoting behaviors; and (2) a Cognitive Behavioral Therapy (CBT) intervention tailored towards addressing chronic stress that contributes to excess weight and maladaptive eating behaviors and results in obesity and CVD. Participants and their caregivers will be randomly placed into either the Lifestyle Medicine Group, CBT Group, or combined Lifestyle Medicine with CBT Group. Participants will respond to questionnaires and surveys measuring lifestyle habits, stress, and psychological risk factors at their first visit, 6-month visit, and 3 months post-intervention visit. Over the course of 6 months, participants will attend virtual sessions (up to three times a month) in accordance with their intervention group.
Trial opening soon.
Get Notified9 year–26 year
All sexes
Interventional
Not applicable
Autistic individuals experience almost three times the mortality rate relative to non-autistic populations, and are disproportionately likely to experience obesity-with increasing rates beginning in childhood and adolescence-relative to both the general population and those with other developmental conditions. Obesity is one of the most common health conditions among autistic young people and its prevalence rises at faster rates for autistic-relative to non-autistic-individuals. This places them at heightened risk for cardiovascular disease (CVD) and mortality before they enter adulthood.
Studies have identified three key contributing factors to CVD outcomes in autistic individuals: unhealthy lifestyle behaviors, Adverse Childhood Experiences (ACEs), and chronic stress. Taken together, this study addresses a critical gap in the field: lack of appropriate and effective healthcare/lifestyle interventions for autistic individuals with CVD and/or experiences of chronic stress that lead to obesity and poor cardiovascular health. These efforts require dedicated interventions selected for their impact on two key mechanisms underlying obesity and CVD: lifestyle and ACEs/chronic stress.
This study will explore the effectiveness of two CVD-focused primary care interventions for autistic individuals (ages 9-26): (1) lifestyle medicine consultations tailored towards supporting health-promoting behaviors; and (2) a Cognitive Behavioral Therapy (CBT) intervention tailored towards addressing chronic stress that contributes to excess weight and maladaptive eating behaviors and results in obesity and CVD. Participants and their caregivers will be randomly placed into either the Lifestyle Medicine Group, CBT Group, or combined Lifestyle Medicine with CBT Group. Participants will respond to questionnaires and surveys measuring lifestyle habits, stress, and psychological risk factors at their first visit, 6-month visit, and 3 months post-intervention visit. Over the course of 6 months, participants will attend virtual sessions (up to three times a month) in accordance with their intervention group.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention is a series of lifestyle medicine consultations.
The intervention is a series of CBT sessions.
Receives both Lifestyle Medicine and CBT interventions
Time frame: Administered at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
A series of instruments designed to help aid in the diagnosis and treatment of children, adolescents, and young adults between the ages of 2 and 25 - captures self- and/or caregiver reported psychological distress.
Time frame: Administered at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
Self- and/or caregiver reported diet, physical activity, sleep, stress, and motivation to change.
Time frame: Administered at Baseline
Captures adverse childhood experiences.
Time frame: Administered at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
Captures general knowledge of nutrition and food groups.
Time frame: Administered at Baseline
Self- and/or caregiver reported diet, physical activity, sleep, and stress.
Time frame: Administered at final intervention visit (6-month mark).
Addresses participant and caregiver experience in the study - captures acceptability and feasibility of intervention.
Time frame: Administered at Baseline
Identifies autism spectrum disorder (ASD) in children and the severity of their symptoms.
Time frame: Administered at Baseline
Captures diagnostic criterion from clinicians when used to diagnose Autism Spectrum Disorder.
Time frame: Administered at Baseline
Used to measure adaptive behaviors and aid in the diagnosis of intellectual and developmental disabilities.
Time frame: Collected at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
Height (cm)
Time frame: Collected at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
Weight (kg)
Time frame: Collected at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
Waist circumference (cm)
Time frame: Collected at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
Blood pressure (mmHg)
Contact information is provided by the study sponsor or research team.
Alice Kuo, MD, PhD
CONTACT
Marisol Macedo, MPH
CONTACT
University of California, Los Angeles
Other
Autism Research Consortium on Physical Health: A Two-Part Intervention to Target Cardiovascular Health
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05157386
ADHD, Anxiety
Stockholm, Stockholm County, Sweden
View Trial DetailsNCT06934915
Autism, Autism Spectrum Disorder
Lexington, Massachusetts, United States
View Trial DetailsNCT07522190
Autism, Autism Spectrum Disorder
Palo Alto, California, United States
View Trial DetailsNCT07661823
ADHD, ADHD - Attention Deficit Disorder With Hyperactivity
Richmond, Virginia, United States
View Trial Details